Global smoking-related deaths averted due to MPOWER policies implemented at the highest level between 2007 and 2020.


Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
07 May 2024
Historique:
received: 05 08 2023
accepted: 27 12 2023
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

In response to the harm caused by tobacco use worldwide, the World Health Organization (WHO) World Health Assembly actioned the WHO Framework Convention on Tobacco Control (FCTC) in 2005. To help countries meet their FCTC obligations, the WHO introduced in 2008 the MPOWER policy package and by 2020 the FCTC had been ratified by 182 parties. The package consists of six evidence-based demand reduction smoking cessation policies to assist countries to achieve best practice. We used published evaluation results and replicated the published model to estimate current policy achievement and demonstrate the impact and equity of the MPOWER policy package in reducing the global number of smokers and smoking-attributable deaths (SADs) between 2007 and 2020. We replicated an evaluation model (the Abridged SimSmoke model) used previously for country impact assessments and validated our replicated reduction in SADs for policies between 2014 and 2016 against the published results. The replicated model was then applied to report on the country level SADs averted from achieving the highest level of implementation, that is best practice in MPOWER policies, between 2016 and 2020. The latest results were then combined with past published results to estimate the reduction in SADs since the commencement of the MPOWER policy package. Country level income status was used to investigate the equity in the uptake of MPOWER policies worldwide. Identical estimates for SADs in 41 out of 56 MPOWER policies implemented in 43 countries suggested good agreement in the model replication. The replicated model overestimated the reduction in SADs by 159,800 (1.5%) out of a total of 10.5 million SADs with three countries contributing to the majority of this replication discrepancy. Updated analysis estimated a reduction of 8.57 million smokers and 3.37 million SADs between 2016 and 2020. Between 2007 and 2020, 136 countries had adopted and maintained at least one MPOWER policy at the highest level which was associated with a reduction in 81.0 million smokers and 28.3 million SADs. Seventy five percent of this reduction was in middle income countries, 20% in high income and less than 5% in low income countries. Considerable progress has been made by MPOWER policies to reduce the prevalence of smokers globally. However, there is inequality in the implementation and maintenance, reach and influence, and the number of SADs averted. Future research to modify the model could provide a more comprehensive evaluation of past and future progress in tobacco control policies, worldwide.

Sections du résumé

BACKGROUND BACKGROUND
In response to the harm caused by tobacco use worldwide, the World Health Organization (WHO) World Health Assembly actioned the WHO Framework Convention on Tobacco Control (FCTC) in 2005. To help countries meet their FCTC obligations, the WHO introduced in 2008 the MPOWER policy package and by 2020 the FCTC had been ratified by 182 parties. The package consists of six evidence-based demand reduction smoking cessation policies to assist countries to achieve best practice. We used published evaluation results and replicated the published model to estimate current policy achievement and demonstrate the impact and equity of the MPOWER policy package in reducing the global number of smokers and smoking-attributable deaths (SADs) between 2007 and 2020.
METHODS METHODS
We replicated an evaluation model (the Abridged SimSmoke model) used previously for country impact assessments and validated our replicated reduction in SADs for policies between 2014 and 2016 against the published results. The replicated model was then applied to report on the country level SADs averted from achieving the highest level of implementation, that is best practice in MPOWER policies, between 2016 and 2020. The latest results were then combined with past published results to estimate the reduction in SADs since the commencement of the MPOWER policy package. Country level income status was used to investigate the equity in the uptake of MPOWER policies worldwide.
RESULTS RESULTS
Identical estimates for SADs in 41 out of 56 MPOWER policies implemented in 43 countries suggested good agreement in the model replication. The replicated model overestimated the reduction in SADs by 159,800 (1.5%) out of a total of 10.5 million SADs with three countries contributing to the majority of this replication discrepancy. Updated analysis estimated a reduction of 8.57 million smokers and 3.37 million SADs between 2016 and 2020. Between 2007 and 2020, 136 countries had adopted and maintained at least one MPOWER policy at the highest level which was associated with a reduction in 81.0 million smokers and 28.3 million SADs. Seventy five percent of this reduction was in middle income countries, 20% in high income and less than 5% in low income countries.
CONCLUSIONS CONCLUSIONS
Considerable progress has been made by MPOWER policies to reduce the prevalence of smokers globally. However, there is inequality in the implementation and maintenance, reach and influence, and the number of SADs averted. Future research to modify the model could provide a more comprehensive evaluation of past and future progress in tobacco control policies, worldwide.

Identifiants

pubmed: 38715053
doi: 10.1186/s12992-023-01012-w
pii: 10.1186/s12992-023-01012-w
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

40

Informations de copyright

© 2024. The Author(s).

Références

GBD 2015 Tobacco Collaborators, Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–906.
doi: 10.1016/S0140-6736(17)30819-X
Ng M, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA. 2014;311(2):183–92.
doi: 10.1001/jama.2013.284692 pubmed: 24399557
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
doi: 10.1371/journal.pmed.0030442 pubmed: 17132052 pmcid: 1664601
World Health Organization (WHO), WHO report on the global tobacco epidemic, 2021: addressing new and emerging products. 2021, WHO: Geneva.
World Health Organisation (WHO), The WHO Framework Convention on Tobacco Control: an overview. May WHO 2021.
Craig L, et al. Impact of the WHO FCTC on tobacco control: perspectives from stakeholders in 12 countries. Tob Control. 2019;28(Suppl 2):s129.
doi: 10.1136/tobaccocontrol-2019-054940 pubmed: 31147481
Puska P, et al. Impact assessment of the WHO Framework Convention on Tobacco Control: introduction, general findings and discussion. Tob Control. 2019;28:S81–3.
doi: 10.1136/tobaccocontrol-2018-054429 pubmed: 30181384
World Health Organization (WHO), WHO Framework Convention on Tobacco Control. 2021.
Dai XC, Gakidou E, Lopez AD. Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control. 2022;31(2):129–37.
doi: 10.1136/tobaccocontrol-2021-056535 pubmed: 35241576
Glahn, A., et al., Tobacco control achievements and priority areas in the WHO Europe Region: A review. Tobacco Prevention & Cessation, 2018. 4.
Severini, G., et al., Towards a smoke-free world? South America became the first 100% smoke-free subregion in the Americas. Revista Panamericana De Salud Publica-Pan American Journal of Public Health, 2022. 46.
Gupta R, et al. Tracking WHO MPOWER in South East Asian region: an opportunity to promote global tobacco control. Journal of Indian Association of Public Health Dentistry. 2016;14(2):218–23.
doi: 10.4103/2319-5932.183808
Abu-Rmeileh NME, et al. Tobacco control in the Eastern Mediterranean region: implementation progress and persisting challenges. Tob Control. 2022;31(2):150–2.
doi: 10.1136/tobaccocontrol-2021-056539 pubmed: 35241580
Heydari, G., A decade after introducing WHO Report on the Global Tobacco Epidemic, trend analysis of implementation of the WHO FCTC MPOWER in Eastern Mediterranean Region. Eur Respir J. 2020;56.
Iqbal, S., et al., Smoking cessation interventions in South Asian Region: a systematic scoping review. Bmc Public Health, 2022. 22(1).
Chung-Hall J, et al. Impact of the WHO FCTC over the first decade: a global evidence review prepared for the Impact Assessment Expert Group. Tob Control. 2019;28:S119–28.
doi: 10.1136/tobaccocontrol-2018-054389 pubmed: 29880598
Anderson, C.L., U. Mons, and V. Winkler, Global progress in tobacco control: the question of policy compliance. Global Health Action, 2020. 13(1).
Hiilamo H, Glantz S. Global Implementation of tobacco demand reduction measures specified in framework convention on tobacco control. Nicotine Tob Res. 2022;24(4):503–10.
doi: 10.1093/ntr/ntab216 pubmed: 34661672
Gravely S, et al. Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries: an association study. The Lancet Public Health. 2017;2(4):e166–74.
doi: 10.1016/S2468-2667(17)30045-2 pubmed: 29253448
Dubray J, et al. The effect of MPOWER on smoking prevalence. Tob Control. 2015;24(6):540–2.
doi: 10.1136/tobaccocontrol-2014-051834 pubmed: 25492934
Anderson CL, Becher H, Winkler V. Tobacco control progress in low and middle income countries in comparison to high income countries. Int J Environ Res Public Health. 2016;13(10):1039.
doi: 10.3390/ijerph13101039 pubmed: 27783060 pmcid: 5086778
Feliu A, et al. Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014. Tob Control. 2019;28(1):101–9.
pubmed: 29472445
Ngo A, et al. The effect of MPOWER scores on cigarette smoking prevalence and consumption. Prev Med. 2017;105:S10–4.
doi: 10.1016/j.ypmed.2017.05.006
Husain MJ, et al. Revisiting the association between worldwide implementation of the MPOWER package and smoking prevalence, 2008–2017. Tob Control. 2021;30(6):630–7.
doi: 10.1136/tobaccocontrol-2020-055758 pubmed: 32893187
Flor LS, et al. The effects of tobacco control policies on global smoking prevalence. Nat Med. 2021;27(2):239-+.
doi: 10.1038/s41591-020-01210-8 pubmed: 33479500 pmcid: 7884287
Ngo A, et al. Global evidence on the association between cigarette graphic warning labels and cigarette smoking prevalence and consumption. Int J Environ Res Public Health. 2018;15(3):421.
doi: 10.3390/ijerph15030421 pubmed: 29495581 pmcid: 5876966
Noar SM, et al. The impact of strengthening cigarette pack warnings: systematic review of longitudinal observational studies. Soc Sci Med. 2016;164:118–29.
doi: 10.1016/j.socscimed.2016.06.011 pubmed: 27423739 pmcid: 5026824
Pang B, et al. The effectiveness of graphic health warnings on tobacco products: a systematic review on perceived harm and quit intentions. BMC Public Health. 2021;21(1):884.
doi: 10.1186/s12889-021-10810-z pubmed: 34011338 pmcid: 8135180
Cheng KW, et al. Association between point-of-sale advertising bans and cigarette smoking. Tobacco Regulatory Science. 2018;4(5):20–9.
doi: 10.18001/TRS.4.5.2
Felsinger R, Groman E. Price Policy and Taxation as Effective Strategies for Tobacco Control. Front Public Health. 2022;10:851740.
doi: 10.3389/fpubh.2022.851740 pubmed: 35450118 pmcid: 9016194
Unal E, Metintas S. Effectiveness of anti-smoking interventions towards community: a meta-analysis study. Cent Eur J Public Health. 2021;29(2):134–42.
doi: 10.21101/cejph.a6350 pubmed: 34245554
World Health Organisation (WHO), MPOWER package of data-driven tobacco control measures helps protect up to 5 billion lives. 2021.
World Health Organization (WHO), It’s time to walk the talk: WHO independent high-level commission on noncommunicable diseases final report. 2019.
Levy DT, et al. Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ. 2013;91(7):509–18.
doi: 10.2471/BLT.12.113878 pubmed: 23825878 pmcid: 3699793
Levy DT, et al. Seven years of progress in tobacco control: an evaluation of the effect of nations meeting the highest level MPOWER measures between 2007 and 2014. Tob Control. 2018;27(1):50.
doi: 10.1136/tobaccocontrol-2016-053381 pubmed: 27956650
Levy DT, Li YM, Yuan Z. Impact of nations meeting the MPOWER targets between 2014 and 2016: an update. Tob Control. 2020;29(2):231–3.
pubmed: 31053650
Levy, D., Y. Li, and Z. Yuan, An evaluation of the effect of nations meeting the MPOWER targets between 2014 and 2016: Report 2020, Georgetown University: Washington, DC.
Doll R, et al. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ. 2004;328(7455):1519.
doi: 10.1136/bmj.38142.554479.AE pubmed: 15213107 pmcid: 437139
Taylor DH Jr, et al. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92(6):990–6.
doi: 10.2105/AJPH.92.6.990 pubmed: 12036794 pmcid: 1447499
United Nations. Department of Economic and Social Affairs Population Division, World population prospects. Online edition. Rev. 2019;1:2019.
World Health Organization. WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies. Geneva: WHO; 2017.
National Cancer Institute. SimSmoke tobacco control policy simulation model. Cancer Intervention and Surveillance Modeling Network [cited 2021 26 Sep]; Available from: https://resources.cisnet.cancer.gov/registry/packages/simsmoke-georgetown/ .
Levy D. The role of public policies in reducing smoking prevalence. In: Bonnie R, Stratton K, Wallace R, editors. Ending the tobacco problem. Washington, DC: National Academic Press; 2007. p. J1–21.
The World Bank. World Bank Country and Lending Groups. 2023 15/05/2023]; Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups .
Levy, D., et al., Complying with the framework convention for tobacco control: an application of the Abridged SimSmoke model to Israel. Israel Journal of Health Policy Research, 2016. 5.
Cunningham R. Tobacco package health warnings: a global success story. Tob Control. 2022;31(2):272–83.
doi: 10.1136/tobaccocontrol-2021-056560 pubmed: 35241600
Nilan K, et al. Progress in implementation of WHO FCTC Article 14 and its guidelines: a survey of tobacco dependence treatment provision in 142 countries. Addiction. 2017;112(11):2023–31.
doi: 10.1111/add.13903 pubmed: 28600886 pmcid: 5655744
Goodchild M, et al. Modelling the expected impact of cigarette tax and price increases under Vietnam’s excise tax law 2015–2020. Tob Control. 2021;30(6):675–9.
doi: 10.1136/tobaccocontrol-2020-055920 pubmed: 33229465
Kumar, N., et al., Tobacco cessation in low- to middle-income countries: A scoping review of randomized controlled trials. Addictive Behaviors, 2021. 112.
Thun M, et al. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21(2):96–101.
doi: 10.1136/tobaccocontrol-2011-050294 pubmed: 22345230
Hebbar, P.B., et al., How do tobacco control policies work in low-income and middle-income countries? A realist synthesis. Bmj Global Health, 2022. 7(11).
Levy DT, et al. Reaching Healthy People 2010 by 2013 A SimSmoke Simulation. Am J Prev Med. 2010;38(3):S373–81.
doi: 10.1016/j.amepre.2009.11.018 pubmed: 20176310 pmcid: 2843137
de Looze, M.E., et al., The association between MPOWER tobacco control policies and adolescent smoking across 36 countries: An ecological study over time (2006–2014). International Journal of Drug Policy, 2022. 109.

Auteurs

Greg Lyle (G)

Curtin University School of Population Health, Perth, Bentley Campus, 6102, Australia. Greg.Lyle@curtin.edu.au.

Delia Hendrie (D)

Curtin University School of Population Health, Perth, Bentley Campus, 6102, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH